AOD 9604 Canada – Research Peptide (5mg)

AOD 9604 Canada – Research Peptide (5mg)

AOD 9604 Canada is supplied by PeptideProCanada in a 5mg lyophilized format for
laboratory-controlled research. It is used in projects involving peptide stability, structural
analysis, and controlled assay development. This compound is intended strictly for qualified Canadian
research environments.

AOD 9604 is a synthetic peptide fragment commonly selected for study designs that evaluate peptide
behaviour, purity comparisons, and long-term stability across repeated assay cycles under controlled
laboratory conditions.

Format & Handling

Each vial contains 5mg of AOD 9604 supplied as a lyophilized powder
in a 3mL sterile glass vial. Standard laboratory procedures should be followed for
reconstitution, handling, and storage. This compound is not intended for therapeutic, diagnostic,
medical, or human use.

Related Research Peptides

Researchers evaluating AOD 9604 Canada may also reference additional peptides for comparative or
parallel models, including
Tesamorelin,
Ipamorelin,
and Cagrilintide.

Canadian Shipping & Availability

PeptideProCanada ships directly from Ontario to support research teams needing predictable delivery
and a reliable domestic supply. Inventory is maintained to ensure consistent access to the
AOD 9604 Canada 5mg format throughout ongoing study periods.

Research-Use-Only Notice

All peptides are supplied solely for laboratory research, analytical
reference, and assay development. They are not for human
consumption, not for clinical or therapeutic use, and not
intended to diagnose, treat, or prevent any condition. All handling must follow institutional
SOPs and applicable regulatory standards.

Certificate of Analysis (COA)

For full quality details, please refer to the second and third images on this page for the Certificate of Analysis (COA) for AOD 9604 Canada 5mg.

For additional research materials, visit the full catalogue of research peptides available in Canada.